| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses | Retrovirology | 2011 | 353 |
| 2 | SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+T-cells | Retrovirology | 2012 | 308 |
| 3 | The discovery of endogenous retroviruses | Retrovirology | 2006 | 296 |
| 4 | Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human | Retrovirology | 2007 | 295 |
| 5 | HIV-1 Vif, APOBEC, and Intrinsic Immunity | Retrovirology | 2008 | 292 |
| 6 | HIV-1 transcription and latency: an update | Retrovirology | 2013 | 279 |
| 7 | Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication | Retrovirology | 2008 | 252 |
| 8 | HIV-1 nef suppression by virally encoded microRNA | Retrovirology | 2004 | 233 |
| 9 | The HTLV-1 Tax interactome | Retrovirology | 2008 | 227 |
| 10 | Macrophages and their relevance in Human Immunodeficiency Virus Type I infection | Retrovirology | 2012 | 226 |
| 11 | Classification and characterization of human endogenous retroviruses; mosaic forms are common | Retrovirology | 2016 | 226 |
| 12 | TRIM5α selectively binds a restriction-sensitive retroviral capsid | Retrovirology | 2005 | 213 |
| 13 | Host-virus interaction: a new role for microRNAs | Retrovirology | 2006 | 212 |
| 14 | HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency | Retrovirology | 2012 | 193 |
| 15 | The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA | Retrovirology | 2015 | 192 |
| 16 | Discovery of adult T-cell leukemia | Retrovirology | 2005 | 191 |
| 17 | MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals | Retrovirology | 2008 | 190 |
| 18 | The control of viral infection by tripartite motif proteins and cyclophilin A | Retrovirology | 2007 | 189 |
| 19 | Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS | Retrovirology | 2014 | 187 |
| 20 | Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies | Retrovirology | 2009 | 185 |
| 21 | HIV interactions with monocytes and dendritic cells: viral latency and reservoirs | Retrovirology | 2009 | 185 |
| 22 | Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology | Retrovirology | 2006 | 184 |
| 23 | Relative resistance of HIV-1 founder viruses to control by interferon-alpha | Retrovirology | 2013 | 184 |
| 24 | HIV-1 encoded candidate micro-RNAs and their cellular targets | Retrovirology | 2004 | 182 |
| 25 | Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa | Retrovirology | 2005 | 182 |
| 26 | Integrase and integration: biochemical activities of HIV-1 integrase | Retrovirology | 2008 | 182 |
| 27 | SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells | Retrovirology | 2007 | 178 |
| 28 | HIV-1 associated dementia: symptoms and causes | Retrovirology | 2006 | 177 |
| 29 | SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+T-lymphocytes cannot be upregulated by interferons | Retrovirology | 2012 | 169 |
| 30 | Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage | Retrovirology | 2010 | 165 |
| 31 | Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity | Retrovirology | 2015 | 165 |
| 32 | Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome | Retrovirology | 2010 | 164 |
| 33 | Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms | Retrovirology | 2005 | 163 |
| 34 | HIV-1 Nef: at the crossroads | Retrovirology | 2008 | 163 |
| 35 | The discovery of the first human retrovirus: HTLV-1 and HTLV-2 | Retrovirology | 2005 | 159 |
| 36 | The macrophage in HIV-1 infection: From activation to deactivation? | Retrovirology | 2010 | 159 |
| 37 | Changes in microRNA expression profiles in HIV-1-transfected human cells | Retrovirology | 2005 | 158 |
| 38 | Retroviral superinfection resistance | Retrovirology | 2005 | 154 |
| 39 | HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment | Retrovirology | 2010 | 154 |
| 40 | HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated | Retrovirology | 2006 | 153 |
| 41 | Identification of endogenous retroviral reading frames in the human genome | Retrovirology | 2004 | 151 |
| 42 | In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) | Retrovirology | 2009 | 151 |
| 43 | HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model | Retrovirology | 2006 | 150 |
| 44 | Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm | Retrovirology | 2008 | 148 |
| 45 | HIV drug resistance against strand transfer integrase inhibitors | Retrovirology | 2017 | 147 |
| 46 | Use of endogenous retroviral sequences (ERVs) and structural markers for retroviral phylogenetic inference and taxonomy | Retrovirology | 2005 | 146 |
| 47 | Early steps of retrovirus replicative cycle | Retrovirology | 2004 | 144 |
| 48 | Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients | Retrovirology | 2009 | 144 |
| 49 | The Spanish HIV BioBank: a model of cooperative HIV research | Retrovirology | 2009 | 143 |
| 50 | Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line | Retrovirology | 2008 | 142 |
